|
REV1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.772200E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.356000E-01 |
| Normal-vs-Stage2 |
7.463000E-01 |
| Normal-vs-Stage3 |
2.501400E-03 |
| Normal-vs-Stage4 |
3.71129999998665E-06 |
| Stage1-vs-Stage2 |
8.123200E-01 |
| Stage1-vs-Stage3 |
3.117200E-03 |
| Stage1-vs-Stage4 |
2.38919999995257E-06 |
| Stage2-vs-Stage3 |
1.127240E-01 |
| Stage2-vs-Stage4 |
1.156220E-02 |
| Stage3-vs-Stage4 |
1.663790E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.572070E-02 |
| Normal-vs-AfricanAmerican |
8.300200E-01 |
| Normal-vs-Asian |
3.069900E-02 |
| Caucasian-vs-AfricanAmerican |
2.179600E-01 |
| Caucasian-vs-Asian |
4.449800E-02 |
| AfricanAmerican-vs-Asian |
1.643810E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.343630E-03 |
| Normal-vs-Female |
7.677000E-01 |
| Male-vs-Female |
4.018100E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.088100E-02 |
| Normal-vs-Age(41-60Yrs) |
4.519000E-01 |
| Normal-vs-Age(61-80Yrs) |
1.296430E-02 |
| Normal-vs-Age(81-100Yrs) |
3.383600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.784100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.660400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.074600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.717800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.808200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.615600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.283600E-03 |
| Normal-vs-Grade 2 |
5.967600E-01 |
| Normal-vs-Grade 3 |
1.941540E-03 |
| Normal-vs-Grade 4 |
1.08489994765648E-09 |
| Grade 1-vs-Grade 2 |
7.903700E-02 |
| Grade 1-vs-Grade 3 |
2.775100E-04 |
| Grade 1-vs-Grade 4 |
1.97080000097216E-08 |
| Grade 2-vs-Grade 3 |
2.187400E-04 |
| Grade 2-vs-Grade 4 |
3.62110341711741E-11 |
| Grade 3-vs-Grade 4 |
1.778800E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.181800E-02 |
| Normal-vs-ccB subtype |
3.19289999994865E-06 |
| ccA subtype-vs-ccB subtype |
3.76539910362794E-11 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.176180E-01 |
| Normal-vs-N1 |
2.593400E-04 |
| N0-vs-N1 |
4.746100E-02 |
|
|
